Navigation Links
InVivo Therapeutics and The Miami Project to Cure Paralysis Form Strategic Research Collaboration to Develop Novel Treatments for Spinal Cord Injuries
Date:5/4/2011

, InVivo's biopolymer devices, alone, combined with drugs, or seeded with human neural stem cells, have demonstrated the remarkable ability to minimize scarring (astrogliosis) and promote post-SCI neural survival.

"We are very pleased to form this partnership with InVivo Therapeutics and look forward to evaluating its innovative biopolymer scaffolding device," said Marc Buoniconti, President of the Miami Project  "We have been working on the problem of SCI for more than 25 years and look forward to exploring another promising avenue in our quest to address the enduring need for effective treatment options. The InVivo team shares our passion and personal commitment to finding new solutions to the challenges of spinal cord injury and paralysis."

Schwann cells are an integral component of The Miami Project's research strategy because they are an important component of the peripheral nervous system.  The cells are known to insulate (myelinate) and promote the growth and regeneration of nerve fibers. In preclinical models, Miami Project scientists have demonstrated locomotor function recovery, spared nerve function and nerve cell growth using autologous Schwann cell transplantation.  The Miami Project has completed preclinical studies and plans to file an Investigational New Drug (IND) application for a Phase 1 human study using Schwann cells with the U.S. Food and Drug Administration in 2011.

"InVivo's biopolymer scaffoldings are novel tissue engineering solutions that may serve to improve functional recovery and promote the proliferation and survival of cellular therapies such as Schwann cells at the site of injury," said W. Dalton Dietrich, III, Ph.D., Scientific Director of The Miami Project. "We see significant potential in the natural synergies from combining these treatment approaches, both of which have been validated in preclinical studies.  The Miami Project team looks forward to elucidating their potential and to worki
'/>"/>

SOURCE The Miami Project; InVivo Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. invivodata and PRO Consulting to Present at International Industry Events
2. invivodata Announces ePROficiency 2009 Web Seminar Series
3. Quintiles Selects invivodata as Primary Partner for ePRO Solutions; Collaboration to Enhance Value, Effectiveness and Speed in Drug Development
4. invivodata Opens Registration for 3rd Annual Patient Reported Outcomes Conference
5. INC Research and invivodata Announce ePRO Partnership
6. invivodata Offers Complimentary PRO Gap Analysis
7. invivodata Delivers Critical Symptom Relief Data in INSYS Therapeutics' Breakthrough Cancer Pain Trial
8. invivodata Expands Spring Educational Program
9. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
10. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
11. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014 This report is a ... industry. For an overview analysis, the report introduces ... chain structure, industry overview, policy analysis, and news ... has witnessed rapid development with key manufacturers ... This report mentions quartz tubing upstream raw materials ...
(Date:12/17/2014)... 17, 2014 Audacity, a leading California-based ... member of the Huntsworth Health Group, is proud to ... team. In her role, Gonzales will serve as Senior ... incredibly honored to welcome a talent of Jamie’s caliber ... Gaëtan Fraikin. “She is a proven healthcare innovation leader ...
(Date:12/17/2014)... , Dec. 17, 2014 CASI Pharmaceuticals, Inc. ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a primary commercial focus on ... been granted a Type C meeting with the U.S. ... will be held in February 2015.  During this meeting ...
(Date:12/15/2014)... METTLER TOLEDO is pleased to announce that ... with PVM technology , is now available. The ... tool continuously captures high-resolution images under a wide ... prepares a report pairing the most relevant images ... This compelling blend of high resolution images and ...
Breaking Biology Technology:2020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2
... The latest in a growing body of shareholder litigation ... dearly. , ,Alleging that members of its management team ... Inc. , a developer of medical imaging and information ... Court. , ,The lawsuits stem from Merge's $325 million ...
... Rights proposal are aiming directly at the heart of ... and municipal governments are necessary to improve Wisconsin's business ... by extension technology investment, in jeopardy. , ,Based in ... development would be handcuffed should the measure be enacted, ...
... biotechnology hot spot will be further enhanced next ... one of the world's premier biotechnology conferences, businesses ... make up 1.5 percent of the total participation ... will be held April 9-12 at Chicago's McCormick ...
Cached Biology Technology:Merge's merger is the crux of shareholder lawsuits 2Critics say tax limits could handcuff tech investment 2Critics say tax limits could handcuff tech investment 3Critics say tax limits could handcuff tech investment 4Critics say tax limits could handcuff tech investment 5Wisconsin to show up at BIO in numbers 2Wisconsin to show up at BIO in numbers 3
(Date:12/10/2014)...     Jifflenow ...   Jifflenow, a leading provider ... business-to-business (B2B) events, today announced a partnership with ... communication (NFC), Bluetooth low energy (BLE), and cloud-based ... Jifflenow will integrate its meeting scheduling ...
(Date:12/5/2014)... -- Tute Genomics, a leader in cloud-based solutions for genome ... led by UK-based Eurovestech. Peak Ventures and a number ... "We are at a pivotal time in ... seeks new approaches for the diagnosis, treatment and prevention ... and CEO of Tute Genomics. "One of the main ...
(Date:12/3/2014)... 2, 2014   Marvin Test Solutions , ... solutions for military, aerospace, and manufacturing organizations, today ... successful TS-900 PXI semiconductor test platform . ... high-end systems to customers at a fraction of ... traditional ATE. "Our semiconductor customers ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... may do serious harm rather than keep you safe ... a cardiologist at UT Southwestern Medical Center. , Runners ... during a race could put themselves at jeopardy for ... the body's sodium content that can result in physical ...
... biologist at Washington University in St. Louis is giving ... unraveling more clues about our biological clock. , VIP ... (VIP), a neuropeptide originally found in the gut, that ... in the brain. , Erik Herzog, Ph.D., Washington University ...
... UNSW researchers have developed three clones of cells from existing ... treatments for diabetes, Parkinson's disease and spinal cord injury. , ... a very accurate way of extracting and then growing a ... is leading the research and is based at the Diabetes ...
Cached Biology News:Too much water may be as dangerous as too little during long-distance athletic events 2Discovery clarifies role of peptide in biological clock 2Stem cell research - new cell lines 2
... targets including proteins and to their modification ... antigens. A&Gs service is divided into ... 40 days (duration may vary slightly dependent ... I: Immunization, test bleed and fusion; $2,500 ...
... Synthetic peptide derived from the N-terminal ... 17 open reading frame 37 (C17orf37 protein) ... C35 protein. On Western blots it identifies ... Reactivity: Human (positive control: full-length human ...
... Two separate vials containing 200 ... same sequence used as antigens for ... 160890) To be ... cyclase polyclonal antiserum (Catalog No. 160890) ...
Immunogen: Secretory component isolated from human colostrum. Storage: 4 C...
Biology Products: